Probability of metachronous testicular cancer in patients with biopsy-proven intratubular germ cell neoplasia depends on first-time treatment of germ cell cancer

Journal of Clinical Oncology

Volumn 30, Issue 32, 2012, Pages 4004-4010

  Brabrand, Sigmund ^a   Fosså, Sophie D ^a   Cvancarova, Milada ^a   Axcrona, Ulrika ^a   Lehne, Gustav ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CARBOPLATIN; CISPLATIN; ETOPOSIDE; IFOSFAMIDE; PACLITAXEL; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; COHORT ANALYSIS; DRUG DOSE ESCALATION; EXPLORATORY RESEARCH; FOLLOW UP; GERM CELL TUMOR; HUMAN; INTRATUBULAR GERM CELL NEOPLASIA UNCLASSIFIED; MAJOR CLINICAL STUDY; MALE; MALE GENITAL TRACT CANCER; ORCHIECTOMY; PRIORITY JOURNAL; SUBSEQUENT TESTICULAR CANCER; TESTIS CANCER;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY; BLEOMYCIN; CHEMOTHERAPY, ADJUVANT; CISPLATIN; DISEASE-FREE SURVIVAL; ETOPOSIDE; GERMINOMA; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY; NORWAY; ORCHIECTOMY; PLATINUM COMPOUNDS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; RISK; TESTICULAR NEOPLASMS; WATCHFUL WAITING;

EID: 84869415703     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.40.8914     Document Type: Article

References (42)

1. Skakkebaek NE: Possible carcinoma-in-situ of the testis. Lancet 2:516-517, 1972
2. Houldsworth J, Korkola JE, Bosl GJ, et al: Biology and genetics of adult male germ cell tumors. J Clin Oncol 24:5512-5518, 2006
3. Skakkebaek NE, Berthelsen JG, Müller J: Carcinoma-in-situ of the undescended testis. Urol Clin North Am 9:377-385, 1982
4. von der Maase H, Rørth M, Walbom-Jørgensen S, et al: Carcinoma in situ of contralateral testis in patients with testicular germ cell cancer: Study of 27 cases in 500 patients. Br Med J (Clin Res Ed) 293:1398-1401, 1986
5. Andreassen KE, Grotmol T, Cvancarova MS, et al: Risk of metachronous contralateral testicular germ cell tumors: A population-based study of 7,102 Norwegian patients (1953-2007). Int J Cancer 129:2867-2874, 2011
6. Pamenter B, De Bono JS, Brown IL, et al: Bilateral testicular cancer: A preventable problem? Experience from a large cancer centre. BJU Int 92:43-46, 2003
7. Dieckmann KP, Loy V: Prevalence of contralateral testicular intraepithelial neoplasia in patients with testicular germ cell neoplasms. J Clin Oncol 14:3126-3132, 1996
8. Dieckmann KP, Loy V, Büttner P: Prevalence of bilateral testicular germ cell tumours and early detection based on contralateral testicular intraepithelial neoplasia. Br J Urol 71:340-345, 1993
9. Mumperow E, Lauke H, Holstein AF, et al: Further practical experiences in the recognition and management of carcinoma in situ of the testis. Urol Int 48:162-166, 1992
10. Fosså SD, Aass N, Heilo A, et al: Testicular carcinoma in situ in patients with extragonadal germ-cell tumours: The clinical role of pretreatment biopsy. Ann Oncol 14:1412-1418, 2003
11. Krege S, Beyer J, Souchon R, et al: European consensus conference on diagnosis and treatment of germ cell cancer: A report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG) - Part I. Eur Urol 53:478-496, 2008
12. Bottomley D, Fisher C, Hendry WF, et al: Persistent carcinoma in situ of the testis after chemotherapy for advanced testicular germ cell tumours. Br J Urol 66:420-424, 1990
13. Christensen TB, Daugaard G, Geertsen PF, et al: Effect of chemotherapy on carcinoma in situ of the testis. Ann Oncol 9:657-660, 1998
14. Dieckmann KP, Loy V: Intratesticular effects of cisplatin-based chemotherapy. Eur Urol 28:25-30, 1995
15. Dieckmann KP, Loy V: The value of the biopsy of the contralateral testis in patients with testicular germ cell cancer: The recent German experience. APMIS 106:13-23, 1998; discussion 20-23
16. Fosså SD, Chen J, Schonfeld SJ, et al: Risk of contralateral testicular cancer: A population-based study of 29,515 U.S. men. J Natl Cancer Inst 97:1056-1066, 2005
17. Hartmann JT, Fossa SD, Nichols CR, et al: Incidence of metachronous testicular cancer in patients with extragonadal germ cell tumors. J Natl Cancer Inst 93:1733-1738, 2001
18. Hentrich M, Weber N, Bergsdorf T, et al: Management and outcome of bilateral testicular germ cell tumors: Twenty-five year experience in Munich. Acta Oncol 44:529-536, 2005
19. Kleinschmidt K, Dieckmann KP, Georgiew A, et al: Chemotherapy is of limited efficacy in the control of contralateral testicular intraepithelial neoplasia in patients with testicular germ cell cancer. Oncology 77:33-39, 2009
20. Oliver RT, Mead GM, Rustin GJ, et al: Randomized trial of carboplatin versus radiotherapy for stage I seminoma: Mature results on relapse and contralateral testis cancer rates in MRC TE19/EORTC 30982 Study (ISRCTN27163214). J Clin Oncol 29:957-962, 2011
21. Oliver RT, Ong J, Berney D, et al: Testis conserving chemotherapy in germ cell cancer: Its potential to increase understanding of the biology and treatment of carcinoma-in-situ. APMIS 111:86-92, 2003
22. Park DS, Prow DM, Amato RJ, et al: Clinical characteristics of metachronous bilateral testicular tumors in the chemotherapeutic era. Yonsei Med J 40:137-143, 1999
23. van Basten JP, Hoekstra HJ, van Driel MF, et al: Cisplatin-based chemotherapy changes the incidence of bilateral testicular cancer. Ann Surg Oncol 4:342-348, 1997
24. van Leeuwen FE, Stiggelbout AM, van den Belt-Dusebout AW, et al: Second cancer risk following testicular cancer: A follow-up study of 1,909 patients. J Clin Oncol 11:415-424, 1993
25. von Ostau C, Krege S, Hartmann M, et al: Metachronous contralateral germ cell tumor 7 years after management of testicular intraepithelial neoplasia by chemotherapy and multiple control biopsies. Scand J Urol Nephrol 35:430-431, 2001
26. Heikkilä R, Heilo A, Stenwig AE, et al: Testicular ultrasonography and 18G biopty biopsy for clinically undetected cancer or carcinoma in situ in patients with germ cell tumours. Br J Urol 71:214-216, 1993
27. Jacobsen KD, Olsen DR, Fosså K, et al: External beam abdominal radiotherapy in patients with seminoma stage I: Field type, testicular dose, and spermatogenesis. Int J Radiat Oncol Biol Phys 38:95-102, 1997
28. von der Maase H, Berthelsen JG, Jacobsen GK, et al: Carcinoma-in-situ of testis eradicated by chemotherapy. Lancet 1:98, 1985
29. Bart J, Groen HJ, van der Graaf WT, et al: An oncological view on the blood-testis barrier. Lancet Oncol 3:357-363, 2002
30. Bart J, Hollema H, Groen HJ, et al: The distribution of drug-efflux pumps, P-gp, BCRP, MRP1 and MRP2, in the normal blood-testis barrier and in primary testicular tumours. Eur J Cancer 40:2064-2070, 2004
31. Fink C, Weigel R, Hembes T, et al: Altered expression of ZO-1 and ZO-2 in Sertoli cells and loss of blood-testis barrier integrity in testicular carcinoma in situ. Neoplasia 8:1019-1027, 2006
32. Rajpert-De Meyts E: Developmental model for the pathogenesis of testicular carcinoma in situ: Genetic and environmental aspects. Hum Reprod Update 12:303-323, 2006
33. Petersen PM, Daugaard G, Rørth M, et al: Endocrine function in patients treated for carcinoma in situ in the testis with irradiation. APMIS 111:93-99, 2003
34. Petersen PM, Giwercman A, Daugaard G, et al: Effect of graded testicular doses of radiotherapy in patients treated for carcinoma-in-situ in the testis. J Clin Oncol 20:1537-1543, 2002
35. Giwercman A, von der Maase H, Berthelsen JG, et al: Localized irradiation of testes with carcinoma in situ: Effects on Leydig cell function and eradication of malignant germ cells in 20 patients. J Clin Endocrinol Metab 73:596-603, 1991
36. Heidenreich A: Contralateral testicular biopsy in testis cancer: Current concepts and controversies. BJU Int 104:1346-1350, 2009
37. Jacobsen KD, Fosså SD, Bjøro TP, et al: Gonadal function and fertility in patients with bilateral testicular germ cell malignancy. Eur Urol 42:229-238, 2002
38. Petersen PM, Giwercman A, Hansen SW, et al: Impaired testicular function in patients with carcinoma-in-situ of the testis. J Clin Oncol 17:173-179, 1999
39. Lampe H, Horwich A, Norman A, et al: Fertility after chemotherapy for testicular germ cell cancers. J Clin Oncol 15:239-245, 1997
40. Fung C, Vaughn DJ: Complications associated with chemotherapy in testicular cancer management. Nat Rev Urol 8:213-222, 2011
41. Fosså SD, Magelssen H: Fertility and reproduction after chemotherapy of adult cancer patients: Malignant lymphoma and testicular cancer. Ann Oncol 15:iv259-iv265, 2004 (suppl 4)
42. Nord C, Bjøro T, Ellingsen D, et al: Gonadal hormones in long-term survivors 10 years after treatment for unilateral testicular cancer. Eur Urol 44:322-328, 2003